Catalyst Healthcare Consulting founder and CEO Nancy Myers, second from right, says FDA staffing shakeup could be an opportunity for sponsors to get a fresh take on their ideas from the agency. Also on the panel at the BioFuture conference are, from left, Yeji Jesse Lee, Law360 senior healthcare reporter; Jennifer Hawks Bland, NewYorkBIO CEO; Cartier Esham, Esham Strategies CEO; and Peter Rubin, No Patient Left Behind executive director. (Source: Alaric DeArment)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
